Earlier Detection, Better Outcomes: Houston Methodist ICU Transfer Results with BioButton

New research from Houston Methodist published in the Journal of Clinical Medicine reveals the life-saving potential of continuous patient monitoring at scale.

Houston Methodist studied 1,120 high-risk patients undergoing transfer to the ICU and found that continuous monitoring with the BioButton® wearable device reduced relative mortality risk by 27% by identifying deterioration at more treatable stages.

The study notes that BioButton's minute-level monitoring enabled care teams to detect physiological deterioration hours earlier than traditional intermittent monitoring, which is particularly useful during vulnerable nighttime hours when staffing is reduced.

Earlier detection translates to better outcomes: shorter hospital stays and improved survival after ICU transfer.

Promising results from Dr. Sarah N Pletcher-Chief Digital Health Officer-and the team at Houston Methodist, and well worth a read: https://www.mdpi.com/2077-0383/14/20/7434

Explore the gallery below for highlights on how BioIntelliSense's continuous monitoring solution is transforming acute care and enabling proactive intervention at the moment it matters most